Combined modality radioprotection: The use of glucan and selenium with WR-2721

International Journal of Radiation Oncology, Biology, Physics

Volumn 18, Issue 5, 1990, Pages 1069-1075

  Patchen, Myra L ^a   Macvittie, Thomas J ^a   Weiss, Joseph F ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Drug interactions; Glucan; Hemopoiesis; Radioprotection; Selenium; WR 2721

Indexed keywords

AMIFOSTINE; GLUCAN; SELENIUM;

ANIMAL EXPERIMENT; ARTICLE; DRUG THERAPY; HEMATOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION;

AMIFOSTINE; ANIMAL; BONE MARROW; COLONY-FORMING UNITS ASSAY; DRUG SYNERGISM; FEMALE; GLUCANS; HEMATOPOIESIS; MICE; MICE, INBRED C3H; ORGANOTHIOPHOSPHORUS COMPOUNDS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; SELENIUM; SPLEEN; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0025336105     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(90)90442-M     Document Type: Article

References (38)

1. Survival-promoting effects of endotoxin in mice, dogs, and sheep
2. Ionizing radiation and the immune response
3. Influence of irradiation on resistance to infection
4. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant
5. Effects of radiation on the hemopoietic system: The bone marrow syndrome
6. Adverse effects of the radioprotector WR2721
7. Nutritional influence on cellular antioxidant defense systems
8. Biological characteristics of some improved radioprotectors
9. Comparative tumor-inhibitory and antibacterial activity of soluble and particulate glucan
10. Radioprotectants
11. Studies on susceptibility to infection following ionizing radiation; time of onset and duration of endogenous bacteremias in mice
12. Effects of vitamin E and selenium on glutathione peroxidase activity and survival in irradiated mice
13. Mouse endogenous spleen counts as a means of screening for anti-radiation drugs
14. Long-term effects of radioprotector WR-2721 on locomotor activity and body weight of mice following exposure to ionizing radiation
15. Polysaccharides induce radioprotection of murine hemopoietic stem cells and increase the LD50/30 days
16. Reduction of short- and long-term radiation lethality by mixtures of chemical protectors
17. Immunomodulators and hemopoiesis
18. Glucan: mechanisms involved in its radioprotective effect
19. The role of macrophages and T-lymphocytes in glucan-mediated alterations of murine hemopoiesis
20. Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immuno modulatory agent glucan
21. Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice
22. Comparative effects of soluble and particulate glucans on survival in irradiated mice
23. Hemopoietic effects of intravenous soluble glucan administration
24. Effects of pre- and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage, and erythroid progenitor cells, and hemopoietic stromal cells
25. A comparison of radiationinduced granulocytopenia in several mammalian species
26. Glucan-induced enhancement of hemopoietic recovery in gamma-irradiated mice
27. A protocol for the determination of absorbed dose from high-energy photon and electron beams
28. Early repair processes in marrow cells irradiated and proliferating in vivo
29. Protection of mouse bone marrow by WR-2721 after fractionated irradiation
30. Analysis of the toxicity and radioprotective effect of the chemical radioprotector WR-2721 in dogs (beagles)
31. Chemical aspects of DNA radioprotection
32. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721
33. Antioxidant mechanisms in radiation injury and radioprotection
34. Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino]ethylphosphorothioic acid (WR-2721): LD 50/30 doses